Gier, Theresa
Koball, Sebastian
Marcello, Matteo
Husain-Syed, Faeq
Ramírez-Guerrero, Gonzalo
Reis, Thiago
Mitzner, Steffen
Schewe, Jens-Christian
Reuter, Daniel
Ronco, Claudio
Klinkmann, Gerd
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 27 April 2025
Accepted: 28 October 2025
First Online: 20 November 2025
Declarations
:
: Not applicable.
: Written consent for publication of clinical details has been obtained from the patient and the parental guardian prior to submission.
: T.R. has received funding for lectures and has been consultant or advisory board member for Alexion, AstraZeneca, B. Braun, Baxter, bioMérieux, Boehringer Ingelheim, Contatti (CytoSorbents), Eurofarma, George Clinical, Jafron, Lifepharma, Medcorp, Nipro, and Nova Biomedical; S. M. is shareholder of Artcline GmbH and received funding for lectures and has been consultant or advisory board member Cytosorbents Europe GmbH; C.R. has been on advisory boards or speaker’s bureau for AstraZeneca, Aferetica, Asahi, B. Braun, Baxter, bioMérieux, CytoSorbents, GE, Medica, Medtronic, and Jafron; G.K. has received funding for lectures for Artcline GmbH and Cytosorbents Europe GmbH and has received research grants from the German Society of Anaesthesiology and Intensive Care.